Brief: PharmaCielo Reports Q3 Loss Per Share $0.05
Nov 30 (Reuters) - Pharmacielo Ltd PCLO.V :
* PHARMACIELO ANNOUNCES FINANCIAL RESULTS FOR THE THIRD
QUARTER
ENDED SEPTEMBER 30, 2020
* PHARMACIELO LTD - QTRLY LOSS PER SHARE $0.05
* PHARMACIELO LTD - EFFECTIVE DECEMBER 1, HENNING VON KOSS
HAS
BEEN NAMED CEO OF PHARMACIELO
* PHARMACIELO LTD - CO HAD CASH AND CASH EQUIVALENTS OF $3.2
MILLION AT SEPTEMBER 30
Source text for Eikon: ID:nCNW9yTfja
Further company coverage: PCLO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmacielo
See all newsBrief: PharmaCielo Receives Purchase Order For API From Brazilian Pharma Company
Brief: Pharmacielo Ltd Intends To Amend Existing Warrant Terms, And Issue Shares For Debt
Brief: PharmaCielo Ltd Reports Quarterly Loss Per Share Of $0.03
Brief: PharmaCielo Announces Shipment Of Dried Cannabis Flower To Czech Republic
Brief: PharmaCielo Announces Receipt Of Production Quota Of THC Dominant Dried Cannabis Flower For Export